Studi clinici su BPCO nello stato di Louisiana
9 studi su BPCO cercano partecipanti presso sedi nello stato di Louisiana.
Città nello stato di Louisiana
Testo ufficiale dello studio (inglese)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Lafayette
- Research Site, Monroe
- Research Site, Shreveport
- e altri 1
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Ochsner LSU Health Shreveport - Academic Medical Center- Site Number : 8400083, Shreveport
- Care Access - Shreveport - Youree Drive- Site Number : 8400007, Shreveport
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Southern Clinical Research - Zachary- Site Number : 8400113, Zachary
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07190209A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Lake Charles
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Zachary
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07082738A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Southern Clinical Research, LLC, Zachary
In reclutamentoFase 2/3
Età da 35 a 80 · Tutti i sessi · Aggiornato il 31 ago 2026 · NCT07363694STRIVE Post-Market Registry Study
- LSU Health Shreveport, Shreveport
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Lake Charles
- GSK Investigational Site, Shreveport
In reclutamentoFase 3
Età da 40 a 75 · Tutti i sessi · Aggiornato il 28 lug 2026 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Baton Rouge
- GSK Investigational Site, Lafayette
- GSK Investigational Site, Shreveport
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 9 apr 2026 · NCT06961214Fonte: ClinicalTrials.gov, dati recuperati il 3 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.